Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade TherapyChristina Pfirschke, Mikaël J. Pittet, Gordon J. Freeman et al.|Immunity|2016Cited by 954
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher Garris, Mikaël J. Pittet, Sean P. Arlauckas et al.|Immunity|2018Cited by 937
Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drugMiles A. Miller, Ralph Weissleder, Yao‐Rong Zheng et al.|Nature Communications|2015Cited by 435
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Mikaël J. Pittet, Nicolas A. Gort-Freitas et al.|Cell|2023Cited by 393
Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF <sup>high</sup> neutrophilsCamilla Engblom, Mikaël J. Pittet, Christina Pfirschke et al.|Science|2017Cited by 377